Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection
Hamidreza Karimi‐Sari(Johns Hopkins University), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Miles Landry(Johns Hopkins University), Katie Zook(Johns Hopkins University), Brian W. Weir(Johns Hopkins University), Kathleen R. Page(Johns Hopkins University), Susan G. Sherman(Johns Hopkins University), Gregory M. Lucas(Johns Hopkins University)
Cited by 0
Related Papers
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
End-Stage Renal Disease Among HIV-Infected Adults in North America
|Clinical Infectious Diseases|2014|172